Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients

Summary

The purpose of this study is to evaluate the overall response rate of Genexol-PM compared with paclitaxel (cremophor-based paclitaxel) as palliative chemotherapy in anthracycline-pretreated patients with metastatic breast cancer.

Timeline

Start

2007-07

Primary completion

2008-08

Completion

2008-10

Outcome

Outcome not reported

Stopped: “withdrawn studies”

Drugs

Indications